This article is more than 5 years old. Information may no longer be current.

Study: IOL injector should be first-line method of insertion

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Use of IOL injectors may result in a lower rate of endophthalmitis, a long-term study found. Because of this, IOL injectors should be considered the preferred method for insertion, the study authors suggest.

A.K. Bates and others with the Taunton and Somerset Hospital in England reviewed all cases of endophthalmitis over a 10-year period occurring in a single ophthalmic unit. Over the course of the study, as extracapsular cataract surgery was replaced with phacoemulsification, the incidence of endophthalmitis was similarly reduced. The lowest risk of postoperative endophthalmitis was associated with the use of IOL injectors, the authors found.

The study is published in the July issue of British Journal of Ophthalmology.